Search
for
Sort by
Research 271–300 of 829
- Alopecia Areata: A tissue specific autoimmune disease of the hair follicle
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- Comparison of Alopecia areata in Human and Nonhuman Mammalian Species
- Alopecia areata − animal models
- The aetiology and pathogenesis of alopecia areata
- Treatment of Alopecia Areata with Anti-Interferon-γ Antibodies
- Getting to the root of hair loss in alopecia
- 35326 Exosome therapy for scalp hair growth—A review of the in vivo and in vitro evidence
- CD8 T cells require IFNg to induce disease in a murine model of Alopecia Areata 2310132
- The pathogenesis model research of alopecia areata: from animal experiments to mathematical prediction models
- Skin γδ T cell subsets have distinct functions in alopecia areata 3844
- 057 Single cell RNA and TCR sequencing reveals hyperexpansion of T cell clones and novel regulatory mechanisms of CD8+ T cells in murine alopcecia areata skin and draining lymph nodes
- 440 Squaric acid dibutylester, used in alopecia areata immunotherapy, promotes innate immune-driven hair growth with CD206+ macrophage accumulation in the dermis
- The emergence of Alopecia Areata is not dependent on perforin-mediated cytolysis
- A Review of Hair Anatomy and Animal Models for Alopecia
- Generation of autoreactive CD8 T cell in a mouse model of alopecia areata
- Novel treatment of alopecia areata with shooting-type candlelit-dissolving microneedle
- 218 Chemokine receptor CCR5 is the novel target for the treatment of alopecia areata
- Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin
- The function of BST2 in γδ T Cells, CD8 T Cells, and macrophages in alopecia areata pathogenesis 4231
- 496 Identification of differentially expressed miRNAs in alopecia areata that target immune-regulatory pathways
- 649 Gut microbiota plays a role in the development of alopecia areata
- 865 Single-cell protein activity inference analysis of full-thickness skin uncovers novel pathways and a rare Arg1+ macrophage population in AA
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- 522 Gut microbiota is required for the development of alopecia areata
- Tolerance induction by hair-specific keratins in murine alopecia areata
- High throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in Alopecia Areata
- Ruxolitinib reverses alopecia areata via a triple mechanism: JAK-STAT inhibition, localized oxidative stress attenuation and selective apoptosis modulation
- CS12192 Reverses Alopecia Areata by Selectively Targeting JAK3/JAK1/TBK1.
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata